Description
June 23, 2025 | 12:00 – 1:00 PM Low Dose Initiation of Buprenorphine
Description:
Join Dr. Solotaroff in an exploration of low-dose buprenorphine initiation. Participants will compare and contrast low-dose initiation protocols across various clinical scenarios, examining the advantages of these protocols when compared to traditional methods in treating patients using fentanyl. Participants will also examine the practical considerations and strategies for implementing low-dose buprenorphine initiation.
Learning Objectives:
- Describe the rationale and core principles of low-dose buprenorphine initiation, including its advantages over traditional induction methods in patients using fentanyl, methadone, and other opioids.
- Compare and contrast low-dose initiation protocols across various clinical scenarios, including outpatient care, level 3.7 withdrawal management settings, and inpatient hospital environments.
- Identify practical considerations and strategies for implementing low-dose buprenorphine initiation, including patient selection, counseling monitoring, and interprofessional collaboration across prescribers and behavioral health clinicians.
- Discuss the use of adjunct medications to improve outcomes with low-dose initiations
Presenter: Rachel Solotaroff, MD
-
- Rachel Solotaroff is the Executive Clinical Director of Substance Use Disorder Services at Penobscot Community Health Care, where she oversees substance use disorders care delivery in the outpatient and inpatient settings. She is also the Medical Director at New Horizons Detox in Hampden,; and the Medical Director at Milestone Recovery, in Portland, Maine. Prior to moving to Maine, Rachel served for nearly 20 years as Chief Medical Officer and then CEO at Central City Concern, an organization that provides health care, supportive housing and supported employment to people experiencing homelessness in Portland, Oregon. Her work has focused on applying a population health approach to the intersection of homelessness, substance use disorders, mental health, trauma, and social isolation. Rachel is a general internist with additional board certification in Addiction Medicine, and holds a Masters in Clinical Research.
Continuing Medical Education:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Hanley Center for Health Leadership and Education and CCSME. The Hanley Center for Health Leadership and Education is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Hanley Center for Health Leadership and Education designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit ™.
This course has been approved by Co-Occurring Collaborative Serving Maine (CCSME), as a NAADAC Approved Education Provider, for 1 educational credits. NAADAC Provider #324712, CCSME is responsible for all aspects of the programming.
Contact Hours 1 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals.
1 Category 1 Contact hours for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contract hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission of Health Education Credentialing, Inc.
